Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Upregulation of Prolactin Receptor Expression and Activation of Prolactin Signaling in an Aggressive Triple-Negative Breast Carcinoma During Pregnancy: A Case Report.

Clinical breast cancer - 1 Oct 2020

Popnikolov Nikolay, Brzezinska Katarzyna, Platoff Rebecca M, Binnebose Rhonda, Rothstein-Rubin Rene, Komarnicky Lydia T, Woodworth Amanda

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, Neoplasm
Share to Neoplasm Metastasis
Share to Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pregnancy Complications, Neoplastic

Share to Prolactin

Share to Receptors, Prolactin

Share to Triple Negative Breast Neoplasms

Share to Up-Regulation

Source

Identifiers

PMID: 32360085
DOI: 10.1016/j.clbc.2020.03.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Upregulation of Prolactin Receptor Expression and Activation of Prolactin Signaling in an Aggressive Triple-Negative Breast Carcinoma During Pregnancy: A Case Report.PMID 32360085Read ↗

Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative PhenotypeSemantic proximity Read ↗

Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential TherapySemantic proximity Read ↗

Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment.Semantic proximity Read ↗

Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analysesSemantic proximity Read ↗

Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasivenessSemantic proximity Read ↗

Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph TumoursSemantic proximity Read ↗

A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.Semantic proximity Read ↗

Breast Cancer and Prolactin – New Mechanisms and ModelsSemantic proximity Read ↗

The Role of Prolactin in Mammary CarcinomaSemantic proximity Read ↗

Prolactin: The New Biology of an Old HormoneSemantic proximity Read ↗

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signatureSemantic proximity Read ↗

Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stromaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.